Microbiome Therapeutics

About:

MicroBiome Therapeutics is a biotechnology company that develops medical food and pharmaceutical products.

Top Investors: New Orleans BioFund, Zehnder Communications, NO/LA Angel Network, BVM Capital, Lagniappe Angels

Description:

MicroBiome Therapeutics is a biotechnology company that develops medical food and pharmaceutical products. The company focuses on developing evidence-based microbiome modulators, which are designed to alter bacteria populations and their environment in the gastrointestinal tract in specific ways to treat and prevent serious health conditions. Its product includes NM504, which contains a combination of prebiotic and other naturally occurring ingredients formulated to help diabetic individuals achieve healthy blood glucose levels and manage their body weight. MicroBiome Therapeutics was formerly known as NuMe Health LLC. The company was founded in 2009 and is based in Broomfield, Colorado.

Total Funding Amount:

$3.04M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Broomfield, Colorado, United States

Founded Date:

2009-01-01

Contact Email:

blindheim(AT)bllbiopartners.com

Founders:

Dale Pfost, John Elstrott

Number of Employees:

1-10

Last Funding Date:

2017-11-01

IPO Status:

Private

Industries: